Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|October 3, 2017
Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease ActivityLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
Arthritis Care & Research|July 25, 2015
Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic ArthritisHilary D Wilson, Alex Mutebi, Dennis A Revicki, et al.
Clinical Rheumatology|March 9, 2017
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registryLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
Future Oncology (London, England)|September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionalsAnna Sureda, Shiraz El Adam, Shibing Yang, et al.
Clinical Rheumatology|July 30, 2019
The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registryNancy A Shadick, Nicole M Gerlanc, Michelle L Frits, et al.
Rheumatology Advances in Practice|November 26, 2019
Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort studyGrant W Cannon, Alan R Erickson, Chia-Chen Teng, et al.
Future Oncology (London, England)|October 21, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the USErin Mulvey, Jason Shafrin, Kyi-Sin Than, et al.
Journal of Medical Economics|June 5, 2019
Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)Louis S Matza, John E Brazier, Katie D Stewart, et al.
Oncoimmunology|July 8, 2026
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphomaLorenzo Falchi, Martin Hutchings, David Tybor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque PsoriasisHema N Viswanathan, Alex Mutebi, Cassandra E Milmont, et al.
Pageof 4